关注
S Sahana
S Sahana
PhD student, CSIR-IGIB
在 indushealthplus.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pharmacogenomic landscape of Indian population using whole genomes
S Sahana, RC Bhoyar, A Sivadas, A Jain, M Imran, M Rophina, ...
Clinical and Translational Science 15 (4), 866-877, 2022
142022
Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes
S Sahana, A Sivadas, M Mangla, A Jain, RC Bhoyar, K Pandhare, ...
Pharmacogenomics 22 (10), 603-618, 2021
72021
Landscape of pharmacogenetic variants associated with non-insulin antidiabetic drugs in the Indian population
A Sivadas, S Sahana, B Jolly, RC Bhoyar, A Jain, D Sharma, M Imran, ...
BMJ Open Diabetes Research and Care 12 (2), e003769, 2024
32024
Genetic epidemiology of monogenic dyslipidemia and statin-associated adverse drug phenotypes in Indian population from whole-genomes of 1029 self-declared healthy individuals
M Imran, RC Bhoyar, A Jain, S Sahana, M Rophina, VR Arvinden, ...
Human Gene 39, 201252, 2024
32024
Development of an In Silico Platform (TRIPinRNA) for the Identification of Novel RNA Intramolecular Triple Helices and Their Validation Using Biophysical Techniques
I Rakheja, V Bharti, S Sahana, PK Das, G Ranjan, A Kumar, N Jain, ...
Biochemistry, 2024
2024
The genomic landscape of CYP2D6 variation in the Indian population
A Sivadas, S Rathore, S Sahana, B Jolly, RC Bhoyar, A Jain, D Sharma, ...
Pharmacogenomics 25 (3), 147-160, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–6